David E. Sprott

Claremont Graduate University — United States

Business, Management and Accounting · Social Sciences

44h-index8.2kcitations153works0.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Consumer Behavior in Brand Consumption and Identification(53), Digital Marketing and Social Media(24), Consumer Market Behavior and Pricing(21), Monoclonal and Polyclonal Antibodies Research(20), Consumer Retail Behavior Studies(20)

Publications152 total

Managing in-store shopping disruptions with technology: the impact of self-service technology on consumer control and decision comfort
Journal of Business Research·2025Open Access
Abstract B007: Tissue-Specific B Cell Differentiation Limits Anti-Tumor Efficacy of Radiation and Immunotherapy
Cancer Immunology Research·2025
Consumer response to corporate political advocacy: the role of policy attitudes, policy change, and perceived controversy
Journal of Business Research·2025· 2 citedOpen Access
Supplementary Table 1 from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
2024Open Access
Supplementary Figure 2 from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
2024Open Access
Data from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
2024Open Access
Supplementary Table 2 from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
2024Open Access
Supplementary Figure 3 from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
2024Open Access
Supplementary Figure 1 from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
2024Open Access
Supplementary Figure 2 from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
2024Open Access
Supplementary Table 3 from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
2024Open Access
Supplementary Table 3 from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
2024Open Access
Data from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
2024Open Access
Supplementary Figure 3 from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
2024Open Access
Supplementary Figure 4 from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
2024Open Access
Supplementary Figure 1 from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
2024Open Access
Supplementary Table 2 from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
2024Open Access
Supplementary Table 1 from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
2024Open Access
Supplementary Figure Legends from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
2024Open Access
Supplementary Figure Legends from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
2024Open Access
page 1 of 8Next →

Frequent Co-authors

Eric R. Spangenberg(14), Anthony D. Miyazaki(10), Kenneth C. Manning(6), Jeff Joireman(5), Linda D. Hollebeek(5), Bianca Grohmann(4), Darrel D. Muehling(3), Andreas Herrmann(3), Sandor Czellar(2), Steven N. Silverman(2), Donald E. Stem(2), Vincent J. Pascal(2), Terence A. Shimp(2), Abdullah J. Sultan(2), Till Weber(2), Chris Hydock(2), Berna Devezer(2), Ann Hansen(2), Alka Varma Citrin(1), Rom S. Leidner(1)